Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
01/2010
01/27/2010EP2146944A1 18f-labelled folates
01/27/2010CN101636368A Separation process
01/27/2010CN100584807C Deuterated catecholamine derivatives and medicaments comprising said compounds
01/21/2010WO2010008522A2 Nucleophilic fluorination of aromatic compounds
01/21/2010WO2010007363A2 Preparation of fluorine-labelled compounds
01/21/2010CA2730734A1 Deuterated benzylbenzene derivatives and methods of use
01/14/2010WO2010003548A1 Process for production of radiopharmaceuticals
01/14/2010CA2729973A1 Process for production of radiopharmaceuticals
01/12/2010CA2471105C Stable isotope-labeled amino acid and method for incorporating the same into target protein, nmr method for the structural analysis of protein and method for producing regio-selective stable isotope-labeled fumaric acid and tartaric acid
01/07/2010WO2010000409A2 Compounds and processes for production of radiopharmaceuticals
01/07/2010CA2729635A1 Compounds and processes for production of radiopharmaceuticals
01/06/2010CN100577213C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts
01/05/2010US7642375 Radiosynthesis of acid chlorides
01/05/2010US7642373 Radical trap in fluoridation of iodonium salt
12/2009
12/31/2009US20090324497 Tc and Re Labeled Radioactive Glycosylated Octreotide Derivatives
12/30/2009WO2009158010A1 Prostacyclin analogs
12/30/2009WO2009156543A1 Deuterated vitamin d compounds
12/24/2009US20090318336 Deuterated Cyclosporine Analogs and Methods of Making the Same
12/23/2009WO2009155309A1 Substituted cyanopyrrolidine derivatives
12/23/2009CN100571787C Para-hydrogen labelled agents and their use in magnetic resonance imaging
12/23/2009CA2725934A1 Novel substituted indoles
12/16/2009EP2132200A2 Nitro-imidazole hypoxia imaging agents
12/03/2009WO2009143985A1 New molecule 5-hydroxy-l-(4-hydroxy-3-[124i]iodo-5-methoxyphenyl)-7- (4-hydroxy-3-methoxyphenyl)-l,4,6-heptatrien-3-one for pet investigations and radiotherapy.
12/03/2009WO2009126844A3 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
12/02/2009EP2128130A1 Process for production of precursor compound for radioactive halogen-labeled organic compound
12/02/2009EP2125698A1 Deuterated venlafaxines and 0-desmethylvenlafaxines with serotoninergic and /or norepinephrinergic activity
12/02/2009EP1663915B1 Method for the production of [18f] fluoride-marked aromatic l-amino acids
12/02/2009CN101595083A [F-18]-labeled l-glutamic acid, [F-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
11/2009
11/26/2009WO2009141091A1 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
11/26/2009WO2009141090A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
11/26/2009WO2009141079A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/26/2009CA2723596A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation
11/26/2009CA2723594A1 {f-19}-labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
11/26/2009CA2723459A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), their use and processes for their preparation
11/25/2009EP2123621A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (1), application thereof and method for their manufacture
11/25/2009EP2123620A1 {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
11/25/2009EP2123619A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (II), application thereof and method for their manufacture
11/25/2009EP2121542A1 Separation process
11/19/2009WO2009139634A1 Radiolabelled mmp selective compounds
11/19/2009WO2009139633A1 Radiolabelled mmp selective compounds
11/18/2009EP2119690A1 Radiolabelled MMP selective compounds
11/18/2009EP2119458A1 Method for production of radiation diagnostic imaging agent
11/18/2009EP2117604A2 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
11/18/2009CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/18/2009CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009US7618613 Method for radiolabeling antibodies with yttrium-90
11/12/2009WO2009087066A3 Method for preparing a marked purine derivative, said derivative and uses thereof
11/11/2009EP2115177A1 Method for the elution of 18f fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabeling without any evaporation step
11/11/2009EP2114873A2 Ligands for imaging cardiac innervation
11/10/2009CA2368652C Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/2009
10/29/2009WO2008140616A3 Nucleophilic radiofluorination using microfabricated devices
10/28/2009EP2111293A2 Nucleophilic radiofluorination using microfabricated devices
10/22/2009WO2009127372A1 Purification strategy for direct nucleophilic procedures
10/22/2009CA2720553A1 Purification strategy for direct nucleophilic procedures
10/21/2009EP2110367A1 Purification strategy for direct nucleophilic procedures
10/21/2009EP2109466A2 Positron emission tomography imaging method
10/21/2009EP1836204B1 Radioactive metal complexes based on bispidine and derivatives thereof
10/21/2009CN101563305A Radiolabelling methods
10/15/2009WO2009126844A2 Derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
10/14/2009EP1572248B1 Solid-phase fluorination of benzothiazoles
09/2009
09/24/2009US20090239837 Cholesterol-producing yeast strains and uses thereof
09/17/2009WO2009114809A1 Therapies for cancer using isotopically substituted lysine
09/17/2009CA2715036A1 Therapies for cancer using isotopically substituted lysine
09/16/2009EP0975595B9 Analogs of cocaine
09/15/2009US7589220 Inhibitors of the anandamide transporter
09/15/2009US7589061 Tc and Re labeler radioactive glycosylated octreotide derivatives
09/09/2009EP2098523A1 Novel compounds with affinity for amyloid
09/09/2009EP2097111A2 Heterodimers of glutamic acid
09/09/2009CN100536926C Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
09/02/2009EP2094625A1 Radiolabelling methods
08/2009
08/26/2009CN101514211A Preparation method for boron-10 neutral complex
08/20/2009WO2009102498A1 Novel imaging agents for detecting neurological dysfunction
08/20/2009CA2715390A1 Imaging agents for detecting neurological dysfunction
08/19/2009EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists
08/19/2009CN101511854A Process for producing radioactive fluorine labeled organic compound, and relevant synthetic apparatus and program
08/13/2009US20090203909 Method and apparatus for the use of [11C] Carbon Monoxide in Labeling Synthesis by Photo-Initiated Carbonylation
08/12/2009EP2086924A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
08/12/2009CN101506128A Method of rapid methylation, kit for preparing pet tracer and method of producing PET tracer
08/11/2009US7572942 Contact perfluoroalkyl metallic compound with carbon dioxide to generate carboxylic acid; contact acid with fluorinating agent; contact product with trifluorooxirane and fluoride ion source; contact with metal halide and heat; track environmental, biological fate of perfluoroalkyls decomposition products
08/06/2009WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring
07/2009
07/29/2009EP2081879A2 Synthesis of isotopically labeled alpha-keto acids and esters
07/16/2009WO2009087066A2 Method for preparing a marked purine derivative, said derivative and uses thereof
07/16/2009CA2710900A1 Method for preparing a marked purine derivative, said derivative and uses thereof
07/02/2009WO2009080561A1 Selective radiolabeling of biomolecules
07/02/2009WO2009080192A1 Method of examining the authenticity of plant protection agents by means of isotopes
07/02/2009WO2009055006A8 Deuterated darunavir
07/02/2009WO2009052970A3 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
07/02/2009CA2705134A1 Selective radiolabeling of biomolecules
07/01/2009EP2074135A2 Silicon derivatives for pet imaging
06/2009
06/25/2009WO2009079413A2 Isotope labeling for determining protein synthesis and protein expression
06/25/2009WO2009078396A1 Process for production of radioactive-fluorine-labeled organic compound
06/25/2009WO2009077386A1 Process for synthesis of tritiated and deuterated thiorphan and acetorphan
06/25/2009WO2008125617A3 18f-labelled folates
06/25/2009CA2709558A1 Process for production of radioactive-fluorine-labeled organic compound
06/24/2009EP2071950A1 Method for testing the authenticity of plant protecting agents through isotopes
06/18/2009WO2009018280A3 Substituted indoles
06/17/2009EP2070937A1 Process for producing radioactive fluorine labeled organic compound, and relevant synthetic apparatus and program
06/17/2009EP2070897A1 Method of rapid methylation, kit for preparing pet tracer and method of producing pet tracer
06/17/2009EP0975595B1 Analogs of cocaine
05/2009
05/28/2009WO2009065789A1 Deuteration of marking materials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 27